Sirkku Peltonen
0000-0003-0990-1430
Publication & Citation Trends
Publications
0 total
Applicability of Novel Laser Scanning Microscopy Techniques in Demonstrating Characteristic Features of Porokeratosis: In Vivo and Ex Vivo Investigation
Cited by 0
Semantic Scholar
Dentofacial Malocclusion in Neurofibromatosis 1 in Finland
Cited by 0
Semantic Scholar
Pregnancy and the Risk for Cancer in Neurofibromatosis 1 OA
Cited by 2
Semantic Scholar
Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin
Cited by 0
Semantic Scholar
Risk and prognosis of myocardial infarction in patients with neurofibromatosis type 1: evidence of compromised survival.
Cited by 0
Semantic Scholar
Exploring MPM-FLIM for diagnostics of porokeratosis - a pilot study ex vivo. OA
Cited by 2
Semantic Scholar
Hospital Visits Associated With Oral Infections in Patients With Neurofibromatosis Type 1: A Register‐Based Analysis OA
Cited by 3
Semantic Scholar
Protocol for high‐intensity focused ultrasound (HIFU) treatment of cutaneous neurofibromas OA
Cited by 1
Semantic Scholar
Research Topics
Neurofibromatosis and Schwannoma Cases
(75)
Soft tissue tumor case studies
(30)
Meningioma and schwannoma management
(21)
Neuroblastoma Research and Treatments
(20)
Immunotherapy and Immune Responses
(11)
Affiliations
AstraZeneca (United Kingdom)
Merck & Co., Inc., Rahway, NJ, USA (United States)
Karolinska University Hospital
University of Helsinki
University of Turku